查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1861326

葡甲胺：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Meglumine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 83 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球葡甲胺市场规模估计为 1,020 万美元，预计到 2031 年将达到 1,419 万美元，2025 年至 2031 年的复合年增长率为 4.1%。

本报告对近期关税调整和国际战略反制措施进行了全面评估，涉及葡甲胺的跨境产业布局、资本配置模式、区域经济相互依存关係以及供应链重组。

葡甲胺是一种白色结晶质粉末，熔点为128-129℃。它易溶于水，微溶于乙醇，几乎不溶于氯仿。它的味道有甜、咸、涩味。其分子式为C7H17NO5，分子量为195.21400。密度为1.375，熔点为128-132℃，沸点为490.4℃（760mmHg）。葡甲胺是一种由葡萄糖衍生的氨基糖。

2024年，全球葡甲胺产量达到约352万吨，全球平均市场价格约每公斤29美元。

葡甲胺市场是製药和医疗化学行业的一个细分市场，其主要驱动力在于其在註射剂、造影剂和其他治疗溶液製剂中作为赋形剂和稳定剂的作用。葡甲胺的需求与製药行业的成长、诊断影像检查的发展以及更广泛的医疗保健基础设施建设密切相关。全球医疗费用支出不断增长、慢性病患病率上升以及新兴市场诊断服务覆盖范围的扩大，都促进了葡甲胺市场的稳定成长。此外，监管机构对高纯度药物成分的重视，也凸显了可靠供应和品质标准在该市场的重要性。

从竞争格局来看，该市场相对集中，生产主要集中在少数几家特种化学品製造商手中。价格受原料成本和医药级化合物严格的合规要求影响。亚太地区存在成长机会，该地区不断扩大的製药产能和医疗影像造影造影需求的成长正在推动消费。然而，市场扩张也面临许多挑战，包括替代辅料的出现、供应链波动以及製造商进入美国和欧洲等监管严格市场所面临的合规障碍。

本报告旨在对全球葡甲胺市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名，并按地区/国家、类型和应用分析葡甲胺市场。

本报告以销售量（吨）和收入（百万美元）为单位，对葡甲胺市场规模、估算和预测进行了呈现，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定葡甲胺业务/成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Merck
  • Tianma
  • Libang Healthcare Group
  • New Hualian Pharm

按类型分類的细分市场

  • 二碘泛酸葡甲胺
  • 罗他拉酸葡甲胺
  • 洛地帕胺葡甲胺

应用领域

  • 助溶剂
  • 造影
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Meglumine was estimated to be worth US$ 10.20 million in 2024 and is forecast to a readjusted size of US$ 14.19 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Meglumine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-1320C and the boiling point is 490.40C at 760 mmHg. Meglumine is an amino sugar derived from glucose.

In 2024, global Meglumine production reached approximately 352 MT, with an average global market price of around US$ 29 per KG.

The meglumine market is a niche segment within the pharmaceutical and medical chemical industry, primarily driven by its role as an excipient and stabilizing agent in the formulation of injectable drugs, contrast media, and other therapeutic solutions. Its demand is closely tied to the growth of the pharmaceutical sector, diagnostic imaging procedures, and the broader healthcare infrastructure. Increasing global healthcare spending, a rise in chronic disease prevalence, and expanding access to diagnostic services in emerging markets contribute to steady growth for meglumine. Additionally, regulatory emphasis on high-purity pharmaceutical ingredients has enhanced the importance of reliable supply and quality standards in this market.

From a competitive standpoint, the market is relatively consolidated, with production concentrated among a limited number of specialized chemical manufacturers. Pricing dynamics are influenced by raw material costs and the stringent compliance requirements for pharmaceutical-grade compounds. Growth opportunities are seen in Asia-Pacific, where expanding pharmaceutical manufacturing capacity and rising demand for contrast media in medical imaging are boosting consumption. However, market expansion may face challenges from substitution by alternative excipients, fluctuating supply chains, and compliance hurdles for manufacturers seeking entry into regulated markets such as the U.S. and Europe.

This report aims to provide a comprehensive presentation of the global market for Meglumine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Meglumine by region & country, by Type, and by Application.

The Meglumine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meglumine.

Market Segmentation

By Company

  • Merck
  • Tianma
  • Libang Healthcare Group
  • New Hualian Pharm

Segment by Type

  • Diatrizoate Meglumine
  • Lothalamate Meglumine
  • Lodipamide Meglumine

Segment by Application

  • Cosolvent
  • Contrast agent
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Meglumine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Meglumine Product Introduction
  • 1.2 Global Meglumine Market Size Forecast
    • 1.2.1 Global Meglumine Sales Value (2020-2031)
    • 1.2.2 Global Meglumine Sales Volume (2020-2031)
    • 1.2.3 Global Meglumine Sales Price (2020-2031)
  • 1.3 Meglumine Market Trends & Drivers
    • 1.3.1 Meglumine Industry Trends
    • 1.3.2 Meglumine Market Drivers & Opportunity
    • 1.3.3 Meglumine Market Challenges
    • 1.3.4 Meglumine Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Meglumine Players Revenue Ranking (2024)
  • 2.2 Global Meglumine Revenue by Company (2020-2025)
  • 2.3 Global Meglumine Players Sales Volume Ranking (2024)
  • 2.4 Global Meglumine Sales Volume by Company Players (2020-2025)
  • 2.5 Global Meglumine Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Meglumine Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Meglumine Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Meglumine
  • 2.9 Meglumine Market Competitive Analysis
    • 2.9.1 Meglumine Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Meglumine Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Diatrizoate Meglumine
    • 3.1.2 Lothalamate Meglumine
    • 3.1.3 Lodipamide Meglumine
  • 3.2 Global Meglumine Sales Value by Type
    • 3.2.1 Global Meglumine Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Meglumine Sales Value, by Type (2020-2031)
    • 3.2.3 Global Meglumine Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Meglumine Sales Volume by Type
    • 3.3.1 Global Meglumine Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Meglumine Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Meglumine Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Meglumine Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Cosolvent
    • 4.1.2 Contrast agent
    • 4.1.3 Other
  • 4.2 Global Meglumine Sales Value by Application
    • 4.2.1 Global Meglumine Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Meglumine Sales Value, by Application (2020-2031)
    • 4.2.3 Global Meglumine Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Meglumine Sales Volume by Application
    • 4.3.1 Global Meglumine Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Meglumine Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Meglumine Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Meglumine Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Meglumine Sales Value by Region
    • 5.1.1 Global Meglumine Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Meglumine Sales Value by Region (2020-2025)
    • 5.1.3 Global Meglumine Sales Value by Region (2026-2031)
    • 5.1.4 Global Meglumine Sales Value by Region (%), (2020-2031)
  • 5.2 Global Meglumine Sales Volume by Region
    • 5.2.1 Global Meglumine Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Meglumine Sales Volume by Region (2020-2025)
    • 5.2.3 Global Meglumine Sales Volume by Region (2026-2031)
    • 5.2.4 Global Meglumine Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Meglumine Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Meglumine Sales Value, 2020-2031
    • 5.4.2 North America Meglumine Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Meglumine Sales Value, 2020-2031
    • 5.5.2 Europe Meglumine Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Meglumine Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Meglumine Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Meglumine Sales Value, 2020-2031
    • 5.7.2 South America Meglumine Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Meglumine Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Meglumine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Meglumine Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Meglumine Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Meglumine Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Meglumine Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Meglumine Sales Value, 2020-2031
    • 6.3.2 United States Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Meglumine Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Meglumine Sales Value, 2020-2031
    • 6.4.2 Europe Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Meglumine Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Meglumine Sales Value, 2020-2031
    • 6.5.2 China Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Meglumine Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Meglumine Sales Value, 2020-2031
    • 6.6.2 Japan Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Meglumine Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Meglumine Sales Value, 2020-2031
    • 6.7.2 South Korea Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Meglumine Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Meglumine Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Meglumine Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Meglumine Sales Value, 2020-2031
    • 6.9.2 India Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Meglumine Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Merck
    • 7.1.1 Merck Company Information
    • 7.1.2 Merck Introduction and Business Overview
    • 7.1.3 Merck Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Merck Meglumine Product Offerings
    • 7.1.5 Merck Recent Development
  • 7.2 Tianma
    • 7.2.1 Tianma Company Information
    • 7.2.2 Tianma Introduction and Business Overview
    • 7.2.3 Tianma Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Tianma Meglumine Product Offerings
    • 7.2.5 Tianma Recent Development
  • 7.3 Libang Healthcare Group
    • 7.3.1 Libang Healthcare Group Company Information
    • 7.3.2 Libang Healthcare Group Introduction and Business Overview
    • 7.3.3 Libang Healthcare Group Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Libang Healthcare Group Meglumine Product Offerings
    • 7.3.5 Libang Healthcare Group Recent Development
  • 7.4 New Hualian Pharm
    • 7.4.1 New Hualian Pharm Company Information
    • 7.4.2 New Hualian Pharm Introduction and Business Overview
    • 7.4.3 New Hualian Pharm Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 New Hualian Pharm Meglumine Product Offerings
    • 7.4.5 New Hualian Pharm Recent Development

8 Industry Chain Analysis

  • 8.1 Meglumine Industrial Chain
  • 8.2 Meglumine Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Meglumine Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Meglumine Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Meglumine Market Trends
  • Table 2. Meglumine Market Drivers & Opportunity
  • Table 3. Meglumine Market Challenges
  • Table 4. Meglumine Market Restraints
  • Table 5. Global Meglumine Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Meglumine Revenue Market Share by Company (2020-2025)
  • Table 7. Global Meglumine Sales Volume by Company (2020-2025) & (MT)
  • Table 8. Global Meglumine Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Meglumine Price by Company (2020-2025) & (USD/Kg)
  • Table 10. Key Manufacturers Meglumine Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Meglumine Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Meglumine
  • Table 13. Global Meglumine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Meglumine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Meglumine Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Meglumine Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Meglumine Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Meglumine Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Meglumine Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
  • Table 22. Global Meglumine Sales Volume by Type (2020-2025) & (MT)
  • Table 23. Global Meglumine Sales Volume by Type (2026-2031) & (MT)
  • Table 24. Global Meglumine Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Meglumine Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Meglumine Price by Type (2020-2025) & (USD/Kg)
  • Table 27. Global Meglumine Price by Type (2026-2031) & (USD/Kg)
  • Table 28. Global Meglumine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Meglumine Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Meglumine Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Meglumine Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Meglumine Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Meglumine Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
  • Table 34. Global Meglumine Sales Volume by Application (2020-2025) & (MT)
  • Table 35. Global Meglumine Sales Volume by Application (2026-2031) & (MT)
  • Table 36. Global Meglumine Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Meglumine Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Meglumine Price by Application (2020-2025) & (USD/Kg)
  • Table 39. Global Meglumine Price by Application (2026-2031) & (USD/Kg)
  • Table 40. Global Meglumine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Meglumine Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Meglumine Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Meglumine Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Meglumine Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Meglumine Sales Volume by Region (MT): 2020 VS 2024 VS 2031
  • Table 46. Global Meglumine Sales Volume by Region (2020-2025) & (MT)
  • Table 47. Global Meglumine Sales Volume by Region (2026-2031) & (MT)
  • Table 48. Global Meglumine Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Meglumine Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Meglumine Average Price by Region (2020-2025) & (USD/Kg)
  • Table 51. Global Meglumine Average Price by Region (2026-2031) & (USD/Kg)
  • Table 52. Key Countries/Regions Meglumine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Meglumine Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Meglumine Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Meglumine Sales Volume, (2020-2025) & (MT)
  • Table 56. Key Countries/Regions Meglumine Sales Volume, (2026-2031) & (MT)
  • Table 57. Merck Company Information
  • Table 58. Merck Introduction and Business Overview
  • Table 59. Merck Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 60. Merck Meglumine Product Offerings
  • Table 61. Merck Recent Development
  • Table 62. Tianma Company Information
  • Table 63. Tianma Introduction and Business Overview
  • Table 64. Tianma Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 65. Tianma Meglumine Product Offerings
  • Table 66. Tianma Recent Development
  • Table 67. Libang Healthcare Group Company Information
  • Table 68. Libang Healthcare Group Introduction and Business Overview
  • Table 69. Libang Healthcare Group Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 70. Libang Healthcare Group Meglumine Product Offerings
  • Table 71. Libang Healthcare Group Recent Development
  • Table 72. New Hualian Pharm Company Information
  • Table 73. New Hualian Pharm Introduction and Business Overview
  • Table 74. New Hualian Pharm Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 75. New Hualian Pharm Meglumine Product Offerings
  • Table 76. New Hualian Pharm Recent Development
  • Table 77. Key Raw Materials Lists
  • Table 78. Raw Materials Key Suppliers Lists
  • Table 79. Meglumine Downstream Customers
  • Table 80. Meglumine Distributors List
  • Table 81. Research Programs/Design for This Report
  • Table 82. Key Data Information from Secondary Sources
  • Table 83. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Meglumine Product Picture
  • Figure 2. Global Meglumine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Meglumine Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Meglumine Sales Volume (2020-2031) & (MT)
  • Figure 5. Global Meglumine Sales Price (2020-2031) & (USD/Kg)
  • Figure 6. Meglumine Report Years Considered
  • Figure 7. Global Meglumine Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Meglumine Players Sales Volume Ranking (2024) & (MT)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Meglumine Revenue in 2024
  • Figure 10. Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Diatrizoate Meglumine Picture
  • Figure 12. Lothalamate Meglumine Picture
  • Figure 13. Lodipamide Meglumine Picture
  • Figure 14. Global Meglumine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Meglumine Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Meglumine Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
  • Figure 17. Global Meglumine Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Meglumine Price by Type (2020-2031) & (USD/Kg)
  • Figure 19. Product Picture of Cosolvent
  • Figure 20. Product Picture of Contrast agent
  • Figure 21. Product Picture of Other
  • Figure 22. Global Meglumine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Meglumine Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Meglumine Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
  • Figure 25. Global Meglumine Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Meglumine Price by Application (2020-2031) & (USD/Kg)
  • Figure 27. North America Meglumine Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Meglumine Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Meglumine Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Meglumine Sales Volume (%), (2020-2031)
  • Figure 39. United States Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Meglumine Industrial Chain
  • Figure 61. Meglumine Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed